Additionally, we will investigate how failure of the interplay between alpha- and beta-cell function contributes to the pathophysiology of diabetes, and furthermore, we will highlight how intra-islet paracrine signaling contributes to the effects of pharmaceutical targeting of the GLP-1R. This evidence concerns the gene GLP1R and diabetes mellitus.